Two Sigma Investments’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Two Sigma Investments’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,744	Closed	-$16.2K	–	3585
2024 Q4	$16.2K	Sell	21,744 -59,347	-73%	-$59.1K	﹤0.01%	3119
2024 Q3	$98.9K	Buy	81,091 +7,369	+10%	+$11.7K	﹤0.01%	2902
2024 Q2	$153K	Buy	+73,722	New	+$174K	﹤0.01%	2778
2024 Q1	–	Sell	-30,133	Closed	-$90.7K	–	3446
2023 Q4	$90.7K	Buy	+30,133	New	+$61.1K	﹤0.01%	2947
2022 Q2	–	Sell	-10,607	Closed	-$66K	–	3028
2022 Q1	$66K	Buy	+10,607	New	+$108K	﹤0.01%	2473

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Two Sigma Investments's OMGA Position: Q1 2025 in Review

Two Sigma Investments sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 21,744 shares — an estimated $16.2K sold.

Two Sigma Investments first reported a position in OMGA in Q1 2022 and held it in 5 quarters. The position peaked at $153K in Q2 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Two Sigma Investments reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Two Sigma Investments sold 21,744 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $16.2K.
Two Sigma Investments first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Two Sigma Investments's Omega Therapeutics, Inc. Common Stock position peaked at $153K in Q2 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.